# Use of a Synthetic Cannabinoid in a Correctional Population for PTSD-Related Insomnia and Nightmares, Chronic Pain, Harm Reduction > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/nabilone-synthetic-cannabinoid-ptsd-insomnia-pain/ > **Published:** 2022-06-28T16:19:07-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:16:34-04:00 > **Clinical Summary:** Explore nabilone synthetic cannabinoid use for PTSD-related insomnia, nightmares, chronic pain, and harm reduction in a correctional population. --- Nabilone, a synthetic compound that mimics THC – the main psychoactive constituent of the plant cannabis, is a medication indicated for preventing nausea and vomiting in cancer patients. In ongoing [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/), it has also demonstrated efficacy for several other conditions, most noticeably the treatment of insomnia and nightmares in patients with psychiatric disorders, the management of [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/), and [harm reduction](https://cedclinic.com/can-you-mix-weed-and-alcohol/) in marijuana dependence. These various benefits make nabilone a promising medication for managing concurrent disorders. Aware of such values, researchers from the Department of Psychiatry, University of Ottawa and the Integrated Forensic Program, Royal Ottawa Health Care Group examined the effectiveness of nabilone in treating a seriously mentally ill correctional population with multiple diagnoses. The study was conducted at the St Lawrence Valley Correctional and Treatment Centre, a hybrid mental health and correctional center. One hundred and four male inmates with concurrent serious mental illnesses were prescribed nabilone and the indications, efficacy, and safety of its use were evaluated. Results showed that patients experienced significant improvement in PTSD-associated insomnia, nightmares, and [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/). Furthermore, on average, nabilone alleviated 3.5 conditions per patient, thus reducing the need for multiple medications. Also worth noticing was that there was no evidence of nabilone abuse within this high-risk population and following initiation of nabilone, many patients were able to discontinue the use of medications associated with greater risk for adverse effects or abuse, such as antipsychotics and sedative/hypnotics. Together, these findings corroborate the potential of nabilone as a safe, effective treatment for patients with concurrent mental disorders in correctional facilities. [More access here](https://cedclinic.com/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series](https://cedclinic.com/cannabidiol-post-traumatic-stress-disorder-treatment/) Explore clinical cases highlighting cannabidiol's role in managing PTSD symptoms including insomnia and nightmares. [Read More](https://cedclinic.com/cannabidiol-post-traumatic-stress-disorder-treatment/) [Endocannabinoid System Clinical Research: Pain Management Trial](https://cedclinic.com/full-spectrum-cannabis-extract-pain-trial/) Review [clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) on the endocannabinoid system's role in [pain management](https://cedclinic.com/cbd-cbg-topicals-for-eczema/) and therapeutic potential. [Explore Study](https://cedclinic.com/full-spectrum-cannabis-extract-pain-trial/) [`Cannabinoid Clinical Trials: Mental Health & Substance Use`](https://cedclinic.com/cannabinoids-mental-health-studies-clinical-trials/) An overview of cannabinoid [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) focusing on mental health and substance use disorders. [Learn More](https://cedclinic.com/cannabinoids-mental-health-studies-clinical-trials/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Use%20of%20a%20Synthetic%20Cannabinoid%20in%20a%20Correctional%20Population%20for%20PTSD-Related%20Insomnia%20and%20Nightmares%2C%20Chronic%20Pain%2C%20Harm%20Reduction&url=https%3A%2F%2Fcedclinic.com%2Fnabilone-synthetic-cannabinoid-ptsd-insomnia-pain%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fnabilone-synthetic-cannabinoid-ptsd-insomnia-pain%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=Use%20of%20a%20Synthetic%20Cannabinoid%20in%20a%20Correctional%20Population%20for%20PTSD-Related%20Insomnia%20and%20Nightmares%2C%20Chronic%20Pain%2C%20Harm%20Reduction%20https%3A%2F%2Fcedclinic.com%2Fnabilone-synthetic-cannabinoid-ptsd-insomnia-pain%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).